文献速递免疫规划传染病防控与疫情报告

表达铜绿假单胞菌OprF的衣壳修饰AdC7载体暴露后免疫可清除铜绿假单胞菌呼吸道感染

Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
PubMed 文献 · Vaccine · 2017-11-07

研究在小鼠(野生型和囊性纤维化模型)和大鼠中建立铜绿假单胞菌RP73持续呼吸道感染,经鼻免疫表达OprF并展示RGD序列的AdC7OprF.RGD载体,诱导了强烈的系统性及黏膜的体液和细胞免疫反应,并有效清除了肺部铜绿假单胞菌;在囊性纤维化小鼠和Sprague Dawley大鼠中同样观察到增强的抗铜绿假单胞菌免疫应答和肺部清除增加。

要点

  • AdC7OprF.RGD经鼻免疫可诱导铜绿假单胞菌特异性系统和黏膜免疫应答。
  • 免疫后野生型小鼠、囊性纤维化小鼠及Sprague Dawley大鼠肺部铜绿假单胞菌清除均增加。
  • 提示AdC7OprF.RGD可作为暴露后疫苗,可能对长期携带该菌的囊性纤维化患者有用。

核心结论

  • AdC7OprF.RGD可能作为有效的暴露后疫苗,并可能在临床环境中特别对长期携带铜绿假单胞菌的囊性纤维化患者有用。

研究设计与样本

  • 研究在野生型小鼠、囊性纤维化小鼠和Sprague Dawley大鼠中,经气管给予包裹在琼脂珠中的临床铜绿假单胞菌株RP73建立持续感染,随后经鼻免疫AdC7OprF.RGD。

主要发现

  • 经鼻免疫AdC7OprF.RGD诱导了强烈的铜绿假单胞菌特异性系统性及黏膜的体液和细胞免疫应答。
  • 免疫的野生型小鼠有效清除了肺部铜绿假单胞菌。
  • 已建立呼吸道感染的囊性纤维化小鼠和Sprague Dawley大鼠经AdC7OprF.RGD免疫后,抗铜绿假单胞菌免疫应答增强,肺部铜绿假单胞菌清除增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Respiratory infections with Pseudomonas aeruginosa are major health problems, particularly in patients with cystic fibrosis (CF). No vaccine against P. aeruginosa is yet available. A vaccine that controls colonization of the respiratory tract with P. aeruginosa could be useful to prevent chronic infection and exacerbations. Replication-deficient adenoviral (Ad) vectors based on non-human serotypes are attractive vaccine platforms as they can circumvent the problem of pre-existing anti-Ad immunity in humans. The primate-based AdC7 vector AdC7OprF.RGD that expresses the outer membrane protein F (OprF) of P. aeruginosa (AdC7OprF) and that displays an integrin-binding arginine-glycine-aspartic acid (RGD) sequence is a potent inducer of lung mucosal and protective immunity. Here, we investigated the efficacy of immunization with AdC7OprF.RGD to clear an already established P. aeruginosa respiratory infection in mice (wild-type and CF) and rats. Intratracheal administration of the clinical P. aeruginosa strain RP73 embedded in agar beads was used to establish persistent infection. Subsequent intranasal immunization with AdC7OprF.RGD induced robust P. aeruginosa-specific systemic and mucosal, humoral and cellular immune responses. Importantly, the AdC7OprF.RGD immunized mice effectively cleared P. aeruginosa from the lungs. Likewise, immunization with AdC7OprF.RGD of CF mice and Sprague Dawley rats with established P. aeruginosa respiratory infection showed enhanced anti-Pseudomonas immune responses and increased clearance of P. aeruginosa from the lungs. These data suggest that AdC7OprF.RGD can be effective as a post-exposure vaccine and may be useful in clinical settings in particular for patients with CF who frequently harbor the bacteria over prolonged periods.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gomi R, Sharma A, Wu W, et al. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection. Vaccine. 2017. PMID: 29126807. doi:10.1016/j.vaccine.2017.10.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。